Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
Source:
cnbc
July 21, 2026 · 04:35
Novo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective advertising.
The original article opens on the publisher's website.
More from General
View topic →Missouri Voters Appear to Recall City Councilman Over Data Center Support
nytimes
Sep 1, 2026 · 19:47
Japanese green tea giant Ito En surges 8%, defying a broad market sell-off
cnbc
Sep 1, 2026 · 19:24
Australia posts second-quarter growth of 2.1%, beating expectations
cnbc
Sep 1, 2026 · 18:47
Fake 10 Downing Street listing exposes 'unfit' Booking.com, says consumer group
bbcTechnology
Sep 1, 2026 · 18:27
Massachusetts’ 80-year-old senator sees off primary challenge over his age
financialTimes
Sep 1, 2026 · 18:06